Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat"
- PMID: 20123428
- DOI: 10.1053/j.tvir.2009.10.002
Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat"
Abstract
Peripheral artery disease (PAD) is a highly prevalent atherosclerotic syndrome associated with significant morbidity and mortality. PAD is defined by atherosclerotic obstruction of the arteries to the legs that reduce arterial flow during exercise or at rest, and is associated with systemic atherosclerosis. The clinical presentation of PAD is quite varied, including patients with atypical leg symptoms, classic intermittent claudication, and critical limb ischemia. Clinical assessment of these patients includes a comprehensive history, physical examination, and noninvasive and invasive vascular studies. The major risk factors for PAD include diabetes mellitus, tobacco abuse, hyperlipidemia, hypertension, and advanced age. Because of the presence of these risk factors, the systemic nature of atherosclerosis, and the high risk of ischemic events, patients with PAD should be candidates for comprehensive secondary prevention strategies, including aggressive glycemic control, all attempts at tobacco cessation, lipid lowering and antihypertensive treatment, antiplatelet therapy, and thorough foot care. This article reviews the comprehensive diagnostic algorithm and medical treatment strategies for patients with infrainguinal PAD.
Similar articles
-
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.Catheter Cardiovasc Interv. 2008 Mar 1;71(4):475-89. doi: 10.1002/ccd.21401. Catheter Cardiovasc Interv. 2008. PMID: 18307227 Review.
-
Imaging evaluation of lower extremity infrainguinal disease: role of the noninvasive vascular laboratory, computed tomography angiography, and magnetic resonance angiography.Tech Vasc Interv Radiol. 2010 Mar;13(1):11-22. doi: 10.1053/j.tvir.2009.10.003. Tech Vasc Interv Radiol. 2010. PMID: 20123429 Review.
-
Peripheral artery disease: therapeutic advances.Expert Rev Cardiovasc Ther. 2008 Apr;6(4):539-53. doi: 10.1586/14779072.6.4.539. Expert Rev Cardiovasc Ther. 2008. PMID: 18402543 Review.
-
Medical treatment of peripheral arterial disease: a comprehensive review.J Vasc Interv Radiol. 2004 Nov;15(11):1197-207. doi: 10.1097/01.RVI.0000137978.15352.C6. J Vasc Interv Radiol. 2004. PMID: 15525738 Review.
-
Treating patients with peripheral arterial disease and claudication.J Vasc Nurs. 2003 Mar;21(1):5-14; quiz 15-6. doi: 10.1067/mvn.2003.2. J Vasc Nurs. 2003. PMID: 12629492 Review.
Cited by
-
S-glutathionylation, friend or foe in cardiovascular health and disease.Redox Biol. 2020 Oct;37:101693. doi: 10.1016/j.redox.2020.101693. Epub 2020 Aug 22. Redox Biol. 2020. PMID: 32912836 Free PMC article. Review.
-
Follow-up after surgical treatment for intermittent claudication (FASTIC): a study protocol for a multicentre randomised controlled clinical trial.BMC Nurs. 2020 Jun 4;19:45. doi: 10.1186/s12912-020-00437-7. eCollection 2020. BMC Nurs. 2020. PMID: 32518518 Free PMC article.
-
Effects of a person-centred, nurse-led follow-up programme on adherence to prescribed medication among patients surgically treated for intermittent claudication: randomized clinical trial.Br J Surg. 2022 Aug 16;109(9):846-856. doi: 10.1093/bjs/znac241. Br J Surg. 2022. PMID: 35848783 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources